Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -3.06% is 84% above its 5-year average of -19.41%, near the high end of its 5-year range (-50.43%–-0.04%).
33.11% above its 12-month average of -4.57%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -5.12%.
NET PROFIT MARGIN
-3.06%
NET PROFIT MARGIN AVG TTM
-4.57%
NET PROFIT MARGIN AVG 3Y
-11.18%
NET PROFIT MARGIN AVG 5Y
-19.41%
NET PROFIT MARGIN AVG 10Y
-58.98%
NET PROFIT MARGIN AVG 15Y
-73.14%
NET PROFIT MARGIN AVG 20Y
-85.93%
CURRENT VS TTM AVG
+33.11%
CURRENT VS 3Y AVG
+72.64%
CURRENT VS 5Y AVG
+84.23%
CURRENT VS 10Y AVG
+94.81%
CURRENT VS 15Y AVG
+95.82%
CURRENT VS 20Y AVG
+96.44%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 691 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Cerus Corporation
Market Cap
$474.59M
Net Profit Margin
-3.06%
TTM Avg
-4.57%
3Y Avg
-11.18%
5Y Avg
-19.41%
Market Cap
$473.83M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
11.36%
5Y Avg
9.09%
Market Cap
$479.89M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$482.94M
Net Profit Margin
2.94%
TTM Avg
-53.14%
3Y Avg
-197.29%
5Y Avg
-267.69%
Market Cap
$490.16M
Net Profit Margin
11.55%
TTM Avg
13.38%
3Y Avg
8.98%
5Y Avg
-0.37%
Market Cap
$491.69M
Net Profit Margin
-10.85%
TTM Avg
-18.16%
3Y Avg
-29.23%
5Y Avg
-75.36%
Market Cap
$453.54M
Net Profit Margin
-2178.90%
TTM Avg
-2455.14%
3Y Avg
-5466.68%
5Y Avg
-3741.67%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cerus Corporation (CERS) | $474.59M | -3.06% | -4.57% | -11.18% | -19.41% |
| Contineum Therapeutics, Inc. (CTNM)vs › | $473.83M | 0.00% | 0.00% | 11.36% | 9.09% |
| Bright Minds Biosciences Inc. (DRUG)vs › | $479.89M | 0.00% | 0.00% | 0.00% | 0.00% |
| Kamada Ltd. (KMDA)vs › | $468.45M | 11.60% | 10.09% | 6.05% | 5.82% |
| Arvinas, Inc. (ARVN)vs › | $482.94M | 2.94% | -53.14% | -197.29% | -267.69% |
| NRC Health (NRC)vs › | $460.30M | 4.18% | 12.88% | 16.89% | 20.14% |
| Puma Biotechnology, Inc. (PBYI)vs › | $490.16M | 11.55% | 13.38% | 8.98% | -0.37% |
| Evolus, Inc. (EOLS)vs › | $491.69M | -10.85% | -18.16% | -29.23% | -75.36% |
| Ovid Therapeutics Inc. (OVID)vs › | $453.54M | -2178.90% | -2455.14% | -5466.68% | -3741.67% |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $454.10M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
-0.7%
Net Profit Margin
-3.1%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -5.12% |
| 2026-03-31 | -3.06% |
| 2025-12-31 | -3.78% |
| 2025-09-30 | -0.04% |
| 2025-06-30 | -10.88% |
| 2025-03-31 | -17.85% |
| 2024-12-31 | -4.96% |
| 2024-09-30 | -6.38% |
| 2024-06-30 | -12.81% |
| 2024-03-31 | -25.25% |
| 2023-12-31 | -2.84% |
| 2023-09-30 | -18.27% |
| 2023-06-30 | -34.17% |
| 2023-03-31 | -50.43% |
| 2022-12-31 | -30.94% |
| 2022-09-30 | -21.43% |
| 2022-06-30 | -20.46% |
| 2022-03-31 | -32.81% |
| 2021-12-31 | -22.87% |
| 2021-09-30 | -34.42% |
| 2021-06-30 | -48.79% |
| 2021-03-31 | -74.67% |
| 2020-12-31 | -51.00% |
| 2020-09-30 | -59.89% |
| 2020-06-30 | -69.16% |
| 2020-03-31 | -88.47% |
| 2019-12-31 | -80.91% |
| 2019-09-30 | -99.71% |
| 2019-06-30 | -96.45% |
| 2019-03-31 | -107.36% |
| 2018-12-31 | -98.06% |
| 2018-09-30 | -92.16% |
| 2018-06-30 | -86.13% |
| 2018-03-31 | -102.37% |
| 2017-12-31 | -70.73% |
| 2017-09-30 | -124.28% |
| 2017-06-30 | -179.35% |
| 2017-03-31 | -265.46% |
| 2016-12-31 | -133.34% |
| 2016-09-30 | -141.29% |
| 2016-06-30 | -196.37% |
| 2016-03-31 | -220.95% |
| 2015-12-31 | -152.82% |
| 2015-09-30 | -194.90% |
| 2015-06-30 | -180.88% |
| 2015-03-31 | -122.98% |
| 2014-12-31 | -206.67% |
| 2014-09-30 | -103.83% |
| 2014-06-30 | -88.23% |
| 2014-03-31 | -2.86% |
| 2013-12-31 | -63.47% |
| 2013-09-30 | -194.47% |
| 2013-06-30 | -66.25% |
| 2013-03-31 | -105.33% |
| 2012-12-31 | -16.30% |
| 2012-09-30 | -41.93% |
| 2012-06-30 | -20.67% |
| 2012-03-31 | -100.59% |
| 2011-12-31 | -76.72% |
| 2011-09-30 | 24.44% |
| 2011-06-30 | -93.48% |
| 2011-03-31 | -75.69% |
| 2010-12-31 | -40.71% |
| 2010-09-30 | -76.78% |
| 2010-06-30 | -91.44% |
| 2010-03-31 | -87.77% |
| 2009-12-31 | -89.31% |
| 2009-09-30 | -117.10% |
| 2009-06-30 | -147.69% |
| 2009-03-31 | -212.07% |
| 2008-12-31 | -164.86% |
| 2008-09-30 | -227.15% |
| 2008-06-30 | -225.63% |
| 2008-03-31 | -106.50% |
| 2007-12-31 | 611.88% |
| 2007-09-30 | -247.32% |
| 2007-06-30 | -396.88% |
| 2007-03-31 | -144.91% |
| 2006-12-31 | 21.27% |
| 2006-09-30 | -22.41% |
| 2006-06-30 | -78.51% |
| 2006-03-31 | -13.29% |
| 2005-12-31 | -69.41% |
| 2005-09-30 | -24.22% |
| 2005-06-30 | -50.38% |
| 2005-03-31 | 334.09% |
| 2004-12-31 | -180.87% |
| 2004-09-30 | -142.98% |
| 2004-06-30 | -306.61% |
| 2004-03-31 | -252.10% |
| 2003-12-31 | -287.32% |
| 2003-09-30 | -495.40% |
| 2003-06-30 | -837.34% |
| 2003-03-31 | -1352.17% |
| 2002-12-31 | -980.72% |
| 2002-09-30 | -2272.74% |
